Wal-mart Pharmacy 10-0689 Durable Medical Equipment & Medical Supplies Location: 177 Washington Dr, Somerset, Kentucky 42501 Phone: (606) 679-8466 |
Walgreens #7664 Durable Medical Equipment & Medical Supplies Location: 600 S Highway 27, Somerset, Kentucky 42501 Phone: (606) 677-0596 |
Wecare Medical Somerset DME Supplier - Oxygen Equipment & Supplies Location: 650 S Highway 27, Somerset, Kentucky 42501 Phone: (606) 677-9472 |
West Somerset Pharmacy Medicare Supplier Location: 647 W Highway 80, Somerset, Kentucky 42503 Phone: (606) 677-1922 |
Xtreme Prosthetics Prosthetic/Orthotic Supplier Location: 1005 W Columbia St, Somerset, Kentucky 42503 Phone: (606) 451-0668 |
News Archive
Scientists researching the causes and effects of hypoxia in Green Bay, part of Lake Michigan, Wisc., have been awarded $348,037 for the first year of an anticipated four-year $1,367,300 project through NOAA's Coastal Hypoxia Research Program. Hypoxia within Green Bay has been a problem for decades, and recent evidence suggests that it may be worsening, with the potential for "dead zones" and fish kills to become both more frequent and more extensive with a changing climate.
Palomar Medical Technologies, Inc., a leading researcher and developer of light-based systems for cosmetic treatments, today announced financial results for the second quarter ended June 30, 2010. Revenues for the quarter ended June 30, 2010 were $15.6 million, which represents a 4 percent increase over the $15.0 million reported in the second quarter of 2009. Product and service revenues increased to $13.0 million, an 8 percent increase over the $12.1 million in the second quarter of 2009.
Skanska has been awarded a contract to build a world-class cancer clinic in London for University College Hospitals NHS Foundation Trust. The contract amount is GBP 61 M, approximately SEK 740 M, which will be included in third-quarter order bookings.
Jazz Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has sent the company a complete response letter (CRL) regarding the company's New Drug Application (NDA) for JZP-6 (sodium oxybate) for the treatment of fibromyalgia. The CRL states that the FDA cannot approve the NDA in its present form.
› Verified 8 days ago